| P50 | author | Hartmut Derendorf | Q43380523 |
| | Cornelius J Clancy | Q96642108 |
| P2093 | author name string | Hong Huang | |
| | M Hong Nguyen | |
| | Shaoji Cheng | |
| P2860 | cites work | In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods | Q28372129 |
| | In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) | Q28379217 |
| | Echinocandin antifungal drugs | Q29398696 |
| | Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods | Q33695704 |
| | Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans | Q33979304 |
| | Pharmacodynamics of caspofungin in a murine model of systemic candidiasis: importance of persistence of caspofungin in tissues to understanding drug activity | Q34228214 |
| | In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis | Q35091285 |
| | Importance of bacterial growth phase in determining minimal bactericidal concentrations of penicillin and methicillin | Q35670767 |
| | Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species | Q37157546 |
| | In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies | Q37598686 |
| | Two forms of antimicrobial resistance: bacterial persistence and positive function resistance | Q38673267 |
| | In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates. | Q39731811 |
| | Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata | Q40668521 |
| | A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis | Q44166464 |
| | Comparison of caspofungin and amphotericin B for invasive candidiasis | Q44255071 |
| | Echinocandins--an advance in the primary treatment of invasive candidiasis | Q44255076 |
| | PERSISTENCE OF STAPHYLOCOCCUS AUREUS IN PENICILLIN IN VITRO. | Q44538222 |
| | A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans | Q44733004 |
| | The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. | Q54428804 |
| | The postantibiotic effect of antifungal agents against common pathogenic yeasts | Q72807287 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida glabrata | Q139137 |
| | Candida parapsilosis | Q144068 |
| | Candida albicans | Q310443 |
| P304 | page(s) | 2569-2572 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments | |
| P478 | volume | 50 | |